Effect of excipients on the stability and aerosol performance of nebulized aviscumine.
D000280:Administration, Inhalation; D000336:Aerosols / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics*; D001682:Biological Availability; D004355:Drug Stability; D004867:Equipment Design; D004869:Equipment Safety; D005079:Excipients / Q000737:chemistry* / Q000494:pharmacology; D006801:Humans; D008962:Models, Theoretical; D009330:Nebulizers and Vaporizers; D000442:Octanols / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics*; D028321:Plant Preparations / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics*; D010940:Plant Proteins; D054790:Ribosome Inactivating Proteins, Type 2; D012680:Sensitivity and Specificity; D013499:Surface Properties; D014118:Toxins, Biological / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics*
D000336:Aerosols; D005079:Excipients; D000442:Octanols; D028321:Plant Preparations; D010940:Plant Proteins; D054790:Ribosome Inactivating Proteins, Type 2; D014118:Toxins, Biological; C009674:ribosome inactivating protein, Viscum